CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 38 enrolled
Drug / intervention
0.2mg Buprenorphine +1 moredrug
Likely dose
0.2mg Buprenorphinefrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02659787
NCT02659787N/ACompleted
CompareCT.gov

Effects of Buprenorphine on Mood in Adults With a Range of Depressive Symptomatology

University of Chicago·interventional·Posted Jan 20, 2016·Updated May 29, 2019

In Brief

A clinical study evaluating 0.2mg Buprenorphine and Placebo for Depression. Completed, enrolled 38 participants across 1 site.

Detailed Summary

This study seeks to to study the effects of buprenorphine, a partial mu-opioid agonist, on depressed mood in a healthy young adults with a range of depressive symptomatology.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 20, 2016
Enrollment StartJun 1, 2016
Primary CompletionApr 1, 2017
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 10.5 years ago

Interventions

0.2mg Buprenorphinedrug

Sublingual buprenorphine tablets (0.2mg)

Placebodrug

Placebo